Developing new nanoparticles for treating muscle disorders
Official title: A novel framework for nanomedicine development
Funded at University of Oklahoma · NIH-10896232 · Data updated 2026-11-12
This study is all about developing tiny particles that can safely carry medicines and genetic materials directly to muscle cells, helping to improve treatments for people with muscle disorders.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Oklahoma NIH-funded |
| Lab location | 1 site (Norman, United States) |
| Project start | September 1, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $373,297 |
| NIH project number | 5R35GM150758-02 |
| Project ID | NIH-10896232 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with skeletal muscle disorders who may benefit from advanced therapeutic options.
✕Less likely to help
Patients with non-muscle related conditions or those who do not have access to the required treatment facilities may not benefit from this research.
What this research studies
This research focuses on creating innovative nanoparticles that can safely and effectively deliver drugs and genetic materials to skeletal muscle cells. The team will explore new methods for tracking how these nanoparticles move within biological systems, ensuring they reach their intended targets. By improving the delivery mechanisms, the research aims to enhance the treatment options available for patients with muscle disorders. The ultimate goal is to make significant advancements in nanomedicine that can lead to better therapies for these conditions.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for patients suffering from muscle disorders.
How similar studies have gone: Previous research in nanomedicine has shown promising results in improving drug delivery systems, indicating potential success for this novel approach.
Where this research is happening
-
University of Oklahoma
Norman, United States Active
Researchers
- Principal investigator: Wilhelm, Stefan — University of Oklahoma
- Study coordinator: Wilhelm, Stefan
Related research
Other NIH-funded projects on the same topics.
-
Personalized 3D molds to shape breast reconstruction
A doctor-relevant project is testing patient-specific 3D printed molds to guide breast reconstruction after mastectomy, aiming to improve body image and quality of life for feminine-presenting individuals.
-
Faster 3D/4D imaging to speed up testing of cancer drugs on tumor organoids
This project builds a new, ultrafast label-free 4D imaging system with AI to watch how patient-like tumor organoids respond to cancer drugs, helping researchers find more promising treatments.
-
How our genes control skin color and pigmentation
Scientists are studying how epigenetic and transcriptional controls shape human skin color and related pigmentation differences.
-
Nanomedicine delivery framework for skeletal muscle therapies
A new framework aims to safely and efficiently deliver tiny nanoparticles carrying drugs or genetic payloads to skeletal muscle cells.
-
Atlas of bacterial drug entry and exit to help design better antibiotics
Researchers are building smart computer models and chemical tests to understand how to get drugs into Gram-negative bacteria like Acinetobacter baumannii so new antibiotics can work.
-
Understanding protein forms in disease with advanced mass spectrometry
A researchers team will use a cutting-edge mass spectrometry approach to map and measure the full shape and connections of disease-related proteins in human biology.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.